These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 6633218)

  • 21. [Reaction of the retinal vascular system to basic vasodilator substances after long-term administration to various sites].
    Bryk E
    Folia Med Cracov; 1986; 27(1-2):9-19. PubMed ID: 3732961
    [No Abstract]   [Full Text] [Related]  

  • 22. [Buflomedil chlorhydrate in the treatment of retinopathies].
    Spallone A; Porta E; Bertazzi E; Ridling P; Ortolina S; Fatigati G; Carlevaro G; Visentin E; Capilli G
    Clin Ter; 1987 Apr; 121(2):125-8. PubMed ID: 2956000
    [No Abstract]   [Full Text] [Related]  

  • 23. [The effects of terazosin hydrochloride and buflomedil in patients with hemicrania without aura].
    Paterna S; Martino S; Ingurgio NC; Arrostuto A; Correo S; Licata G
    Clin Ter; 1994 Apr; 144(4):307-19. PubMed ID: 7911406
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical and hemorheological effects of buflomedil in diabetic subjects with intermittent claudication.
    Diamantopoulos EJ; Grigoriadou M; Ifanti G; Raptis SA
    Int Angiol; 2001 Dec; 20(4):337-44. PubMed ID: 11782701
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Use of buflomedil chlorhydrate in vertiginous patients. Vertigo].
    Pianura CM; Di Lillo ML; Galati F; Massatani M; Mignano M
    Minerva Cardioangiol; 1985 Jun; 33(6):369-72. PubMed ID: 4047427
    [No Abstract]   [Full Text] [Related]  

  • 26. [Assay of buflomedil in biologic media. Determination of different pharmacokinetic parameters].
    Fredj G; Clenet M; Rousselet F
    Therapie; 1978; 33(3):321-32. PubMed ID: 684684
    [No Abstract]   [Full Text] [Related]  

  • 27. Pharmacological preconditioning of ischaemia.
    Laghi Pasini F; Capecchi PL; Acciavatti A; Petri S; de Lalla A; Cati G; Colafati M; Di Perri T
    Clin Hemorheol Microcirc; 1997; 17(1):73-84. PubMed ID: 9181761
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Action of Buflomedil on the cutaneous microcirculation studies by a cold provocation test. Multicenter, double-blind, placebo controlled trial].
    Maurel A; Betrancourt JC; Van Frenkel R; Thuillez C
    J Mal Vasc; 1995; 20(2):127-33. PubMed ID: 7650439
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Poisoning by buflomedil (Fonzylane)].
    Bléry C; Douet N; Fleureaux O; Artus M; Hermès D; Malledant Y
    Cah Anesthesiol; 1992; 40(2):129-30. PubMed ID: 1628233
    [No Abstract]   [Full Text] [Related]  

  • 30. Improvement of microcirculation abnormalities in sickle cell patients upon buflomedil treatment.
    Bachir D; Maurel A; Beuzard Y; Razavian M; Kraiem A; Portos JL; Galacteros F
    Microvasc Res; 1993 Nov; 46(3):359-73. PubMed ID: 8121319
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Effect of buflomedil perfusion on peripheral tissue oxygenation during transluminal angioplasty in patients with advanced arteriopathy of the lower limbs].
    Joffre F; Meites G; Rousseau H; Staffin C; Allaert FA; Pelat P
    Ann Radiol (Paris); 1994; 37(3):239-44. PubMed ID: 8092756
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Blood levels, distribution in the organs and excretion of carbochromen in rat, dog and man].
    Schraven E; Nitz RE; Klarwein M
    Arzneimittelforschung; 1970 Dec; 20(12):1905-11. PubMed ID: 5537095
    [No Abstract]   [Full Text] [Related]  

  • 33. [Local application of buflomedil. Value in the treatment of subcutaneous tissue loss].
    Gadenne-Tesse C
    Soins; 1990 Jun; (537):57-8. PubMed ID: 2389169
    [No Abstract]   [Full Text] [Related]  

  • 34. [Status epilepticus following voluntary poisoning with buflomedil].
    Morcamp D; Carrara O; Valuet M
    Ann Med Interne (Paris); 1993; 144(3):213-4. PubMed ID: 8368707
    [No Abstract]   [Full Text] [Related]  

  • 35. [Acute fatal poisoning with buflomedil].
    Danel V; Saviuc P; Vincent F; Barret L; Debru JL
    J Toxicol Clin Exp; 1988; 8(4):243-6. PubMed ID: 3216338
    [No Abstract]   [Full Text] [Related]  

  • 36. [Pharmacokinetics study of furosemide in healthy man (author's transl)].
    Gonzalez G; Arancibia A; Marinovic G; Moya JC; Antezana C; Ruiz I
    Therapie; 1980; 35(4):525-32. PubMed ID: 7466733
    [No Abstract]   [Full Text] [Related]  

  • 37. [Use of the vasodilator molsidomin in the treatment of chronic cardiac insufficiency].
    Mareev VIu; Sazonova LN; Grigor'iants RA; Lobova NM; Irani RM
    Ter Arkh; 1983; 55(9):76-80. PubMed ID: 6688891
    [No Abstract]   [Full Text] [Related]  

  • 38. The use of buflomedil in reduction mammaplasty for a previously irradiated breast: a case report.
    Sterodimas A; Vargas A; Radwanski HN; Pitanguy I
    Aesthetic Plast Surg; 2008 Mar; 32(2):383-5. PubMed ID: 18058164
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of buflomedil on in vitro prostacyclin and endothelin synthesis by vascular (rat and human) and penile (rat) tissue and calcium uptake by isolated human platelets.
    Jeremy JY; Gill J; DuBourg A; Pelat P; Mikhailidis DP
    Int J Impot Res; 1993 Sep; 5(3):139-47. PubMed ID: 8124432
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Myoclonus during treatment with buflomedil].
    Leys D; Pavy G; Bourgeois P; Petit H
    Therapie; 1985; 40(6):481. PubMed ID: 4089790
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.